Aditxt stock.

Nov 30, 2023 · Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move ...

Aditxt stock. Things To Know About Aditxt stock.

Nov 30, 2023 · Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move ... 14 giờ trước ... ADTX has a roughly average overall score of 40 meaning the stock holds a better value than 40% of stocks at its current price.4 ngày trước ... Cision PR Newswire · Thinking about buying stock in Aditxt Inc, Ampio Pharmaceuticals, TOP SHIPS, Mullen Automotive, or Oatly Group ? · Get News ...Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on August 1, 2022, as amended. ...

Stock Ticker Symbol Market Type; Aditxt Inc: ADTX: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded . 0.18: 5.28%: 3.59: 00:00:01: Open Price Low Price High Price Close PriceStock Ticker Symbol Market Type; Aditxt Inc: ADTX: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded . 0.18: 5.28%: 3.59: 00:00:01: Open Price Low Price High Price Close Price

Aditxt stock price has plummeted: avoid at all cost. Aditxt (NASDAQ: ADTX) stock price has been in the spotlight in the past few days. The shares plunged by more than 24% on Friday, one of its worst days this year.Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on July 20, 2023, as amended ...

4 days ago ... Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.The Series A warrants permit the holder to purchase one share of common stock at an exercise price of $9.00 and expire after 5 years. The Series B warrants are exercisable at $11.25 per share.Which Aditxt insiders have been selling company stock? The following insider sold ADTX shares in the last 24 months: Paribas Securities Corp Bnp ($691,184.00). How much insider selling is happening at Aditxt?Aditxt stock price from Google Finance. As we can see that price rise went away again and rather rapidly at that. There’s also been the reverse stock split at Aditxt: “Aditxt (NASDAQ: ADTX) stock should rise 4,000% at the open. ADTX stock also rose 32% yesterday but these are two entirely and wholly different things.Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on July 20, 2023, as amended ...

Aditxt Inc ( ADTX) has risen Thursday morning, with the stock climbing 5.31% in pre-market trading to 10.32. ADTX's short-term technical score of 40 indicates that the stock has traded less bullishly over the last month than 60% of stocks on the market. In the Biotechnology industry, which ranks 134 out of 146 industries, the stock ranks higher ...

View the latest Aditxt Inc. (ADTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Aditxt climbs 32% postmarket after completing 1-for-50 reverse stock split SA News Tue, Sep. 13, 2022 Aditxt stock surges 61% on positive preclinical toxicity study of its psoriasis drug candidateWhat is Aditxt's Market Cap? ( NASDAQ: ADTX) Aditxt 's market cap is $2.03M, as of Oct 13, 2023. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Aditxt 's market cap is calculated by multiplying ADTX 's current stock price of $10.65 by ADTX 's total outstanding shares of 190,268.While the stock has been plunging for a while now, ADTX stock is grabbing investors attention in the meantime after the company effected a reverse spl Aditxt, Inc. (NASDAQ: ADTX) is a promising biotech company with a main focus of developing technologies that improve the health of the immune system. While the stock has been plunging for a while ... Aditxt (NASDAQ:ADTX) stock climbed ~32% postmarket on Tuesday after the firm effected a 1-for-50 reverse stock split.The firm's stock will trade on a post-split basis under the ticker "ADTX" after ...Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move ...Short interest for Aditxt gives investors a sense of the degree to which investors are betting on the decline of Aditxt's stock. Short interest data is updated every two weeks.4 days ago ... Thinking about buying stock in Aditxt Inc, Ampio Pharmaceuticals, TOP SHIPS, Mullen Automotive, or Oatly Group ? By InvestorsObserver, Aditxt ...

Aditxt, Inc. ADTX fell 15.1% to $3.3710 after jumping 15% on Thursday. ... Fathom Holdings announced proposed primary and secondary offering of common stock.Nov 30, 2023 · Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. No new press releases or filings with the Securities and Exchange Commission (SEC ... Short interest for Aditxt gives investors a sense of the degree to which investors are betting on the decline of Aditxt's stock. Short interest data is updated every two weeks.Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ...17 thg 11, 2023 ... Amro Albanna, CEO of Aditxt, Inc., was recently interviewed by Benzinga. Aditxt is an innovation platform commercializing promising ...

Find the latest analyst research for Aditxt, Inc. Common Stock (ADTX) at Nasdaq.com.The reverse stock split is primarily intended to bring the Company into compliance with Nasdaq’s minimum bid price requirement. Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on July 20, 2023, as amended. About Aditxt, Inc.

Dec 1, 2023 · Aditxt has an Altman Z-Score of -31.7 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. -31.7. Piotroski F-Score. 3. Detailed statistics for Aditxt, Inc. (ADTX) stock, including valuation metrics, financial numbers, share information and more. Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and …Aditxt, Inc. ADTX shares rose 126.1% to $7.80 in pre-market trading. ... jumped 93% on Wednesday after the company effected a 1-for-10 reverse stock split for its Class A and Class B common stock.See the company profile for Aditxt, Inc. (ADTX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...Jul 8, 2022 · Aditxt (NASDAQ: ADTX) stock is soaring 74% to 28 cents in late morning trading on much heavier-than-usual volume. The rally of ADTX was sparked by positive preclinical data reported by the company ... Aditxt Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules Business Wire - Thu Apr 20, 12:35PM CDT . Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that...

Aditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules. RICHMOND, Va., September 06, 2023--Aditxt, Inc., (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it ...

RICHMOND, Va., August 31, 2023--Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating ...

Nov 27, 2023 · Aditxt's stock was trading at $46.1840 at the beginning of 2023. Since then, ADTX shares have decreased by 92.6% and is now trading at $3.41. View the best growth stocks for 2023 here. Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.Nov 27, 2023 · Aditxt's stock was trading at $46.1840 at the beginning of 2023. Since then, ADTX shares have decreased by 92.6% and is now trading at $3.41. View the best growth stocks for 2023 here. Aditxt (NASDAQ:ADTX) filed a prospectus to the resale by selling stockholders of up to 264,516 shares of common stock. This prospectus is not an offer to sell. Filing Aditxt appoints Ernie Lee as ...Get the latest Aditxt Inc (ADTX) stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's financial performance, balance sheet, cash flow, and earnings per share for the second quarter of 2023. Using data from Stockcharts, ADTX opened 2023 at a price of $44. Therefore, even with the upswing in shares today, Aditxt’s stock is down about 58%. In addition, investment data aggregator ...Investors in Aditxt, Inc. ADTX need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 17, 2022 $2.50 Call had some of the highest implied ...Using data from Stockcharts, ADTX opened 2023 at a price of $44. Therefore, even with the upswing in shares today, Aditxt’s stock is down about 58%. In addition, investment data aggregator ...

Get Aditxt Inc (ADTX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsStock analysis for Aditxt Inc (ADTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.The purpose of this Amendment No. 1 on Form 10-K/A (the “Amendment”) is to amend and restate Part III, Items 10 through 14 of the previously filed Annual Report on Form 10-K of Aditxt, Inc. (the “Company”) for the year ended December 31, 2022, filed with the Securities and Exchange Commission on April 17, 2023 (the “Original Form 10-K”), to …Instagram:https://instagram. how to purchase stock directly from a companyboomi revenue 2022healthcare workers mortgage assistancerare quater 31 thg 8, 2023 ... Aditxt Inc (ADTX) has risen Thursday morning, with the stock climbing 5.31% in pre-market trading to 10.32. ADTX's short-term technical ...Aditxt, Inc. analysts consensus, targets, ratings and recommendations | Nasdaq: ADTX | Nasdaq use credit card to buy stocksaccd Apr 15, 2023 · Aditxt's stock closed Friday at 87.49 cents per share. Pfizer's stock closed at $41.19. Amro Albanna, the co-founder, chairman and CEO of Richmond, Virginia-based Aditxt, contended that picking ... While the stock has been plunging for a while now, ADTX stock is grabbing investors attention in the meantime after the company effected a reverse spl Aditxt, Inc. (NASDAQ: ADTX) is a promising biotech company with a main focus of developing technologies that improve the health of the immune system. While the stock has been plunging for a while ... mlbar Frequently Asked Questions for Aditxt, Inc. Shareholders Aditxt stock is traded on the Nasdaq Capital Market exchange under the ticker symbol ADTX, and its common stock CUSIP number is 007025505. Aditxt’s initial public offering (IPO) occurred on July 2, 2020. Vstock Transfer, LLC is Aditxt’s transfer agent. Vstock Transfer, LLC18 LafayetteAditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of an aggregate of 1,585,350 shares of common stock (or common ...